232 related articles for article (PubMed ID: 15870379)
1. Role of cytochrome B5 in modulating peroxide-supported cyp3a4 activity: evidence for a conformational transition and cytochrome P450 heterogeneity.
Kumar S; Davydov DR; Halpert JR
Drug Metab Dispos; 2005 Aug; 33(8):1131-6. PubMed ID: 15870379
[TBL] [Abstract][Full Text] [Related]
2. Topological changes in the CYP3A4 active site probed with phenyldiazene: effect of interaction with NADPH-cytochrome P450 reductase and cytochrome b5 and of site-directed mutagenesis.
Yamaguchi Y; Khan KK; He YA; He YQ; Halpert JR
Drug Metab Dispos; 2004 Jan; 32(1):155-61. PubMed ID: 14709633
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
Inui H; Maeda A; Ohkawa H
Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
[TBL] [Abstract][Full Text] [Related]
5. Interaction of apo-cytochrome b5 with cytochromes P4503A4 and P45017A: relevance of heme transfer reactions.
Guryev OL; Gilep AA; Usanov SA; Estabrook RW
Biochemistry; 2001 Apr; 40(16):5018-31. PubMed ID: 11305918
[TBL] [Abstract][Full Text] [Related]
6. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
[TBL] [Abstract][Full Text] [Related]
7. The role of cytochrome b5 structural domains in interaction with cytochromes P450.
Sergeev GV; Gilep AA; Usanov SA
Biochemistry (Mosc); 2014 May; 79(5):406-16. PubMed ID: 24954591
[TBL] [Abstract][Full Text] [Related]
8. Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation.
Khan KK; He YQ; Domanski TL; Halpert JR
Mol Pharmacol; 2002 Mar; 61(3):495-506. PubMed ID: 11854429
[TBL] [Abstract][Full Text] [Related]
9. 7-Benzyloxyquinoline oxidation by P450eryF A245T: finding of a new fluorescent substrate probe.
Khan KK; Halpert JR
Chem Res Toxicol; 2002 Jun; 15(6):806-14. PubMed ID: 12067248
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug.
Lin HL; Zhang H; Medower C; Hollenberg PF; Johnson WW
Drug Metab Dispos; 2011 Feb; 39(2):345-50. PubMed ID: 21068193
[TBL] [Abstract][Full Text] [Related]
11. CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.
Locuson CW; Wienkers LC; Jones JP; Tracy TS
Drug Metab Dispos; 2007 Jul; 35(7):1174-81. PubMed ID: 17446262
[TBL] [Abstract][Full Text] [Related]
12. Cysteine 98 in CYP3A4 contributes to conformational integrity required for P450 interaction with CYP reductase.
Wen B; Lampe JN; Roberts AG; Atkins WM; David Rodrigues A; Nelson SD
Arch Biochem Biophys; 2006 Oct; 454(1):42-54. PubMed ID: 16959210
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions.
Yamazaki H; Gillam EM; Dong MS; Johnson WW; Guengerich FP; Shimada T
Arch Biochem Biophys; 1997 Jun; 342(2):329-37. PubMed ID: 9186495
[TBL] [Abstract][Full Text] [Related]
14. Electron transfer properties and catalytic competence of cytochrome b5 in the fusion protein Hmwb5-EGFP in reactions catalyzed by cytochrome P450 3A4.
Yantsevich AV; Gilep AA; Usanov SA
Biochemistry (Mosc); 2009 Aug; 74(8):862-73. PubMed ID: 19817686
[TBL] [Abstract][Full Text] [Related]
15. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of interactions of alpha-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probe.
Tsalkova TN; Davydova NY; Halpert JR; Davydov DR
Biochemistry; 2007 Jan; 46(1):106-19. PubMed ID: 17198380
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis of cytochrome P450eryF: implications for substrate oxidation, cooperativity, and topology of the active site.
Khan KK; He YA; He YQ; Halpert JR
Chem Res Toxicol; 2002 Jun; 15(6):843-53. PubMed ID: 12067252
[TBL] [Abstract][Full Text] [Related]
18. Electron shuttle between membrane-bound cytochrome P450 3A4 and b5 rules uncoupling mechanisms.
Perret A; Pompon D
Biochemistry; 1998 Aug; 37(33):11412-24. PubMed ID: 9708976
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional effects of cytochrome
Bart AG; Scott EE
J Biol Chem; 2017 Dec; 292(51):20818-20833. PubMed ID: 29079577
[TBL] [Abstract][Full Text] [Related]
20. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
Loughran PA; Roman LJ; Miller RT; Masters BS
Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
